Microwave ablation combined with tirelizumab and fuquinitinib in the treatment of third-line and posterior advanced colorectal cancer patients: a single-arm, open, single-center clinical study

ABSTRACT: Interventions: Experimental group:Microwave ablation combined with tirelizumab and fuquintinib Primary outcome(s): progression free survival Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 38520 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR